UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020426
Receipt number R000023314
Scientific Title The influence of cold exposure and analysis of abnormalities in ion channels in neuromuscular diseases
Date of disclosure of the study information 2016/01/05
Last modified on 2023/02/06 09:37:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The influence of cold exposure and analysis of abnormalities in ion channels in neuromuscular diseases

Acronym

The influence of cold exposure and analysis of abnormalities in ion channels in neuromuscular diseases

Scientific Title

The influence of cold exposure and analysis of abnormalities in ion channels in neuromuscular diseases

Scientific Title:Acronym

The influence of cold exposure and analysis of abnormalities in ion channels in neuromuscular diseases

Region

Japan


Condition

Condition

Neuromuscular diseases
Healty subjects

Classification by specialty

Medicine in general Neurology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Cold exposure may deteriorate motor paralysis and myotonia in the patients with neuromuscular diseases. Dysfunctions of the ion channels existing in the skeletal muscle cell membrane cause the symptoms such as motor paralysis and myotonia. However, the reasons for the dysfunctions have not been clear in the most of neuromuscular diseases other than primary muscular ion channelopathies. The aim of this study is to examine the influence of cold exposure in subjects with neuromuscular diseases and healthy controls by performing the muscular strength measurement and peripheral nerve conduction studies under the room temperature and the cold exposure.

Basic objectives2

Others

Basic objectives -Others

We prospectively examine the quantitative muscular strength measurement and peripheral nerve conduction studies surrounding cold exposures in subjects with neuromuscular disorders and healthy controls.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Grip power

Key secondary outcomes

Tongue pressure
Peripheral nerve conduction studies
Blood examinations
Brain MRI/MRA
Cervical spine MRI
Pulmonary function test
Dual-energy X-ray Absorption(DXA)
ADL scales
Timed walk test(15 feets)
Rise from bed test
modified quantitative myasthenia gravis score


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Patients with neuromusucular disorders
2)Healthy controls

Key exclusion criteria

1)severe complications such as cardiovascular diseases
2)Other severe complications
3)The patients who are judged inappropriate for a participant of this study

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahisa Katsuno

Organization

Nagoya University Graduate School of Medicine

Division name

Neurology

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan

TEL

052-744-2385

Email

ka2no@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shinichiro Yamada

Organization

Nagoya University Graduate School of Medicine

Division name

Neurology

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan

TEL

052-744-2390

Homepage URL


Email

s.yamada@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

JSPS

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2015 Year 10 Month 06 Day

Date of IRB

2015 Year 10 Month 06 Day

Anticipated trial start date

2016 Year 01 Month 01 Day

Last follow-up date

2019 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This observational study was conducted in compliance with the Declaration of Helsinki, Ethical Guidelines for Human Genome/Gene Analysis Research, and Ethical Guidelines for Medical and Health Research Involving Human Subjects and was approved by the Ethics Review Committee of Nagoya University Graduate School of Medicine.


Management information

Registered date

2016 Year 01 Month 04 Day

Last modified on

2023 Year 02 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023314


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name